Biohaven Therapeutics Ltd.

This study looked at the long-term safety of a new daily medication called BHV-7000 for people with major depressive disorder. A total of 233 adults who had already completed an earlier study took the pill once a day. Researchers tracked side effects, lab results, and heart chang…

This study tested whether a new drug called BHV-7000 can safely and effectively treat manic episodes in people with bipolar I disorder. 274 hospitalized adults took either the drug or a placebo once daily for 21 days. The main goal was to see if the drug reduced mania symptoms, m…

This study tested an experimental drug called BHV-2100 for quickly stopping migraine pain and related symptoms like nausea or sensitivity to light. About 647 people with migraines took either the drug or a placebo. The goal was to see if the drug could provide pain relief within …

This study tested whether a new drug called BHV-7000 can safely reduce depression symptoms in adults with moderate to severe major depressive disorder. About 336 participants took either the drug or a placebo for 6 weeks, and doctors measured changes using a standard depression r…